Abstract
Rationale
Activity levels in patients with pulmonary arterial hypertension (PAH) have correlated with surrogate markers of disease severity. It is not known whether physical activity measures are useful in monitoring patients with PAH.
Objectives
This pilot study aimed to evaluate whether change in physical activity measured by an accelerometer correlates with changes in six-minute walk distance (6MWD), echocardiographic parameters, NT-proBNP, or health-related quality-of-life measures (HRQOL).
Methods
The study design was a prospective, observational study in subjects with prevalent PAH. Subjects wore a wrist-worn accelerometer (Fitbit Charge HR®) between two outpatient visits. Daily step count and activity levels were recorded, and the change over time was correlated with changes in 6MWD, echocardiographic parameters, HRQOL, and NT-proBNP.
Measurements and Main Results
30 subjects were enrolled, of which 20 patients had adequate accelerometer data to be analyzed over the study duration. The mean duration of follow-up was 136.4 ( ± 47.3) days. The change in daily step count correlated with a change in 6MWD (r 0.43, p 0.05). Changes in duration spent in moderately active (r 0.52, p 0.02), lightly active (r 0.48, p 0.05), and sedentary activity levels (r − 0.54, p 0.02) correlated with a change in HRQOL. Changes in activity levels did not correlate with echocardiographic measures or NT-pro BNP.
Conclusions
Changes in daily step count and time spent at fairly active, lightly active, and sedentary activity levels correlate with changes in 6MWD, and HRQOL in subjects with PAH suggesting that accelerometry may be a useful monitoring tool.
Similar content being viewed by others
Abbreviations
- 6MWD:
-
Six-minute walk distance
- 6MWT:
-
Six-minute walk test
- BMI:
-
Body mass index
- CTEPH:
-
Chronic thromboembolic disease
- ERA:
-
Endothelin receptor antagonist
- HRQOL:
-
Health-related quality of life
- PA:
-
Pulmonary artery
- PAH:
-
Pulmonary arterial hypertension
- PCWP:
-
Pulmonary capillary wedge pressure
- PDE-5:
-
Phosphodiesterase type 5
- PVR:
-
Pulmonary vascular resistance
- RA:
-
Right atrium
- RHC:
-
Right heart catheterization
- RV:
-
Right ventricle
- SPD:
-
Steps per day
- TAPSE:
-
Tricuspid annular plane systolic excursion
- VAS:
-
Visual analog scale
- WHO FC:
-
World health organization functional class
- WSPH:
-
World Symposium on pulmonary hypertension
References
Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, Nakanishi N, Miyatake K (2012) Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Am J Respir Crit Care Med. https://doi.org/10.1164/ajrccm.161.2.9906015#.V03ik_nhDIU
Taichman DB, Shin J, Hud L, Archer-Chicko C, Kaplan S, Sager JS, Gallop R, Christie J, Hansen-Flaschen J, Palevsky H (2005) Health-related quality of life in patients with pulmonary arterial hypertension. Respir. Res. 6:92. https://doi.org/10.1186/1465-9921-6-92
F. Pitta, T. Troosters, V.S. Probst, M. a Spruit, M. Decramer, R. Gosselink, Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J Off J Eur Soc Clin Respir Physiol 27:1040–1055. https://doi.org/10.1183/09031936.06.00064105
Okumus G, Aslan GK, Arseven O, Ongen G, Issever H, Kıyan E, Mauritz G-J, Rizopoulos D, Groepenhoff H, Tiede H, Felix J, Eilers P, Bosboom J, Postmus PE, Westerhof N, Vonk-Noordegraaf A, Pugh ME, Buchowski MS, Robbins IM, Newman JH, Hemnes AR (2012) Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension. Am. J. Cardiol. 142:1391–1398. https://doi.org/10.1378/chest.12-0150
Dhillon SS, Sima CA, Kirkham AR, Syed N, Camp PG (2015) Physical Activity Measurement Accuracy in Individuals With Chronic Lung Disease: A Systematic Review With Meta-Analysis of Method Comparison Studies. Arch. Phys. Med. Rehabil. 96:2079–2088. https://doi.org/10.1016/j.apmr.2015.05.015
Chen M-D, Kuo C-C, Pellegrini CA, Hsu M-J (2016) Accuracy of wristband activity monitors during ambulation and activities. Med Sci Sports Exerc. https://doi.org/10.1249/MSS.0000000000000984
Pugh ME, Buchowski MS, Robbins IM, Newman JH, Hemnes AR (2012) Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension. Chest 142:1391–1398. https://doi.org/10.1378/chest.12-0150
Zijlstra WMH, Ploegstra M-J, Vissia-Kazemier T, Roofthooft MTR, du Sarvaas GM, Bartelds B, Rackowitz A, van den Heuvel F, Hillege HL, Plasqui G, Berger RMF (2017) Physical activity in pediatric pulmonary arterial hypertension measured by accelerometry. A candidate clinical endpoint. Am J Respir Crit Care Med 196:220–227. https://doi.org/10.1164/rccm.201608-1576OC.
González-Saiz L, Santos-Lozano A, Fiuza-Luces C, Sanz-Ayán P, Quezada-Loaiza CA, Ruiz-Casado A, Alejo LB, Flox-Camacho A, Morán M, Lucia A, Escribano-Subías P (2018) Physical activity levels are low in patients with pulmonary hypertension. Ann. Transl. Med. 6:205–205. https://doi.org/10.21037/atm.2018.05.37
Ulrich S, Fischler M, Speich R, Bloch KE (2013) Wrist actigraphy predicts outcome in patients with pulmonary hypertension. Respiration. 86:45–51. https://doi.org/10.1159/000342351
Hogg RV, Tanis EA, Zimmerman DL (2014) Probability and statistical inference, 9th edn. Pearson
Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery J-L, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G, Rubin L, Zellweger M, Simonneau G (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. 34:1219–1263. https://doi.org/10.1183/09031936.00139009
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23(2010):685–713; quiz 786–8. https://doi.org/10.1016/j.echo.2010.05.010
R.M. Lang, L.P. Badano, V. Mor-Avi, J. Afilalo, A. Armstrong, L. Ernande, F.A. Flachskampf, E. Foster, S.A. Goldstein, T. Kuznetsova, P. Lancellotti, D. Muraru, M.H. Picard, E.R. Rietzschel, L. Rudski, K.T. Spencer, W. Tsang, J.-U. Voigt, Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, Eur. Hear. J. – Cardiovasc. Imaging. 16 (2015) 233–271. https://doi.org/10.1093/ehjci/jev014
Van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS (2012) Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Heal. 15:708–715. https://doi.org/10.1016/j.jval.2012.02.008
Physical Activity and Your Heart | National Heart, Lung, and Blood Institute (NHLBI) (n.d.). https://www.nhlbi.nih.gov/health-topics/physical-activity-and-your-heart. Accessed July 4, 2018.
Frost AE, Langleben D, Oudiz R, Hill N, Horn E, McLaughlin V, Robbins IM, Shapiro S, Tapson VF, Zwicke D, DeMarco T, Schilz R, Rubenfire M, Barst RJ (2005) The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: Demonstration of a ceiling effect. Vascul. Pharmacol. 43:36–39. https://doi.org/10.1016/j.vph.2005.03.003
Gaine S, Simonneau G (2013) The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension. Eur. Respir. Rev. 22:487–494. https://doi.org/10.1183/09059180.00006213
V. Mainguy, S. Provencher, F. Maltais, S. Malenfant, D. Saey (2011) Assessment of daily life physical activities in pulmonary arterial hypertension, PLoS ONE. https://doi.org/10.1371/journal.pone.0027993
Poms AD, Turner M, Farber HW, Meltzer LA, McGoon MD (2013) Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: A reveal registry analysis. Chest 144:169–176. https://doi.org/10.1378/chest.11-3241
Chung AE, Basch EM (2015) Potential and challenges of patient-generated health data for high-quality cancer care. J. Oncol. Pract. 11:195–197. https://doi.org/10.1200/JOP.2015.003715
Rival G, Lacasse Y, Martin S, Bonnet S, Provencher S (2014) Effect of pulmonary arterial hypertension-specific therapies on health-related quality of life: a systematic review. Chest 146:686–708. https://doi.org/10.1378/chest.13-2634
Mathai SC, Puhan MA, Lam D, Wise RA (2012) The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 186:428–433. https://doi.org/10.1164/rccm.201203-0480OC
Sehgal S, Small B, Highland KB (2019) Activity monitors in pulmonary disease. Respir Med. https://doi.org/10.1016/j.rmed.2019.03.019.
Côté J, Cartier A, Malo JL, Rouleau M, Boulet LP (1998) Compliance with peak expiratory flow monitoring in home management of asthma. Chest 113(1998):968–972. https://www.ncbi.nlm.nih.gov/pubmed/9554633. Accessed April 12, 2018.
Verschelden P, Cartier A, L’Archevêque J, Trudeau C, Malo JL (2018) Compliance with and accuracy of daily self-assessment of peak expiratory flows (PEF) in asthmatic subjects over a three month period., Eur. Respir. J. 9 (1996) 880–5. https://www.ncbi.nlm.nih.gov/pubmed/8793446. Accessed April 12, 2018.
Funding
This study was funded by United Therapeutics.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest:
Sameep Sehgal—United Therapeutics: Research Funding. Kristin B Highland—Actelion Pharmaceuticals: research funding, speaker's bureau; Bayer Healthcare: Research funding, Speaker's bureau; Boehringer Ingelheim: Consulting, Steering Committee, Research Funding, Speaker's Bureau; Eiger Pharmaceuticals: Research funding; Genetech: Research funding; Gilead Sciences: Speaker's Bureau; Reata Pharmaceuticals: Research funding; United Therapeutics: Research Funding.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sehgal, S., Chowdhury, A., Rabih, F. et al. Counting Steps: A New Way to Monitor Patients with Pulmonary Arterial Hypertension. Lung 197, 501–508 (2019). https://doi.org/10.1007/s00408-019-00239-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-019-00239-y